Medically reviewed by Dr. Diala Alatassi.
If you've been searching for "oral Zepbound," you're not alone — and you're onto something real. Eli Lilly's oral GLP-1 pill, branded Foundayo (orforglipron), won FDA approval in April 2026, and it's changed the conversation for Philadelphia residents who want GLP-1-level weight loss without a weekly needle. It isn't literally Zepbound in pill form, but it comes from the same manufacturer and works on the same hormone pathway that made Zepbound and Mounjaro household names. This guide breaks down what Foundayo actually is, how it compares to injectable options, what it may cost in Pennsylvania, and how to get a free video visit through TeleSlim Clinic Philadelphia to find out if it's right for you.
What Is Foundayo, and Is It Really "Oral Zepbound"?
Foundayo and Zepbound are not the same drug, even though people often use the terms interchangeably. Zepbound's active ingredient is tirzepatide, a dual GIP/GLP-1 receptor agonist given by weekly injection. Foundayo's active ingredient is orforglipron, a GLP-1-only medication built as a small, non-peptide molecule — which is exactly why it can be swallowed as a once-daily tablet instead of injected. Both drugs come from Eli Lilly and both work by slowing digestion, curbing appetite, and helping the brain register fullness sooner.
So when Philadelphia patients ask about "oral Zepbound," what they usually mean is: is there a pill version of Lilly's powerful weight-loss medications? The honest answer is not yet in tirzepatide form — but Foundayo delivers a similar once-daily, no-injection experience using a different, single-hormone mechanism. In clinical trials, patients on the highest dose lost an average of over 12% of their body weight over about a year and a half, alongside improvements in waist size, cholesterol, and blood pressure. For people who've avoided GLP-1 treatment specifically because of needle anxiety or the hassle of cold-chain storage, Foundayo is a genuinely new option worth discussing with a provider.
How Foundayo Compares to Oral Wegovy and Injectable Options
Foundayo isn't the only pill on the market. Oral Wegovy (semaglutide) was approved a few months earlier and requires patients to take it first thing in the morning, on an empty stomach, with no more than a few sips of water, then wait 30 minutes before eating. Foundayo skips those restrictions entirely — it can be taken any time of day, with or without food, which makes it easier to build into a normal routine.
Compared with injectable tirzepatide (Zepbound, Mounjaro) or injectable semaglutide (Wegovy, Ozempic), Foundayo trades a small amount of average weight loss for convenience and needle-free dosing. Injectables still tend to produce the largest average results in head-to-head data, so the "best" choice really depends on your health history, goals, and comfort level — which is exactly what a licensed provider should help you sort through rather than guessing from social media.
Pennsylvania Telehealth Rules and What a TeleSlim Philadelphia Visit Looks Like
Pennsylvania is one of the more telehealth-friendly states in the country: state law doesn't impose special requirements for how a practitioner-patient relationship must be established for non-controlled medications, and a live video visit is enough to get started — no in-person exam required. That's exactly how TeleSlim Clinic Philadelphia operates: every new patient completes a live video visit with a board-certified provider, who obtains informed consent and reviews your health history before any medication, including Foundayo, is prescribed.
TeleSlim is video-visit only — there's no in-person office to travel to and no compounded medications involved. Once your provider determines eligibility, your prescription is sent electronically to whichever licensed retail pharmacy you prefer, anywhere in the Philadelphia area, from Center City to Fishtown, South Philly, Manayunk, or out to the Main Line suburbs. Most patients hear back the same day and can pick up their first fill within 24–48 hours, depending on the pharmacy's stock.
Eligibility, Safety, and Side Effects to Know Before You Start
Foundayo is approved for adults with obesity, or adults who are overweight with at least one weight-related condition such as high blood pressure, high cholesterol, or prediabetes. Eligibility is typically assessed using BMI, weight history, and current health conditions during your video visit.
Like other GLP-1 medications, Foundayo carries a boxed warning regarding thyroid C-cell tumors seen in rodent studies (a class-wide precaution, not something unique to Foundayo), and it isn't recommended for anyone with a personal or family history of certain thyroid cancers or MEN 2 syndrome. Common side effects include nausea, constipation, diarrhea, and stomach upset, which tend to ease as your body adjusts to the medication. More serious but less common risks include pancreatitis, gallbladder problems, and kidney injury from dehydration if vomiting or diarrhea are severe. Your TeleSlim provider will review your full medical history and current medications before prescribing, and will check in regularly once you start treatment.
Beyond Foundayo: Other Weight Loss Medications TeleSlim Offers
Foundayo is one option among several. TeleSlim Clinic Philadelphia providers also prescribe injectable semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), oral Wegovy, liraglutide (Saxenda), and non-GLP-1 options like phentermine, phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and metformin, depending on what fits your health profile and goals. Your provider will walk through the pros and cons of each during your visit rather than steering you toward a single product.
Frequently Asked Questions
Is Foundayo the same thing as oral Zepbound? No. Foundayo (orforglipron) is a different medication from Zepbound (tirzepatide). Both are made by Eli Lilly and target similar appetite pathways, but Foundayo is a single-hormone GLP-1 pill, while Zepbound is an injectable dual-hormone drug. There is currently no oral tirzepatide product on the market.
How much does Foundayo cost for Philadelphia patients? Self-pay pricing has been reported around a few hundred dollars a month through manufacturer channels, with lower copays possible for some insured or Medicare Part D patients. Your exact cost depends on your insurance and pharmacy, so it's worth confirming during your TeleSlim consult.
How quickly will I see results on Foundayo? Most people notice reduced appetite within the first few weeks, with more meaningful weight loss typically building over 12 to 16 weeks and continuing over several months as the dose is gradually increased.
Can I switch from an injectable GLP-1 to Foundayo? Many patients do transition between formulations under provider guidance. Whether it's right for you depends on your current dose, response, and health history — a good topic to raise during your TeleSlim video visit.
Ready to Find Out if Foundayo Is Right for You?
If you're curious whether Foundayo, oral Wegovy, or an injectable GLP-1 fits your goals, TeleSlim Clinic Philadelphia makes it easy to find out. Book a free eligibility visit, meet with a board-certified provider by video, and get a personalized plan — with your prescription sent straight to your preferred Philadelphia-area pharmacy if you're a candidate. Book your free consult today at https://join.teleslimclinic.com/free-visit.
